Bioventix PLC (AIM:BVXP)
2,875.00
+25.00 (0.88%)
May 13, 2025, 4:35 PM GMT+1
Bioventix Revenue
Bioventix had revenue of 6.73M GBP in the half year ending December 31, 2024, with 14.20% growth. This brings the company's revenue in the last twelve months to 13.66M, up 0.49% year-over-year. In the fiscal year ending June 30, 2024, Bioventix had annual revenue of 13.61M with 6.17% growth.
Revenue (ttm)
13.66M
Revenue Growth
+0.49%
P/S Ratio
10.90
Revenue / Employee
803.74K
Employees
17
Market Cap
148.91M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 13.61M | 790.36K | 6.17% |
Jun 30, 2023 | 12.82M | 1.10M | 9.36% |
Jun 30, 2022 | 11.72M | 788.68K | 7.22% |
Jun 30, 2021 | 10.93M | 617.01K | 5.98% |
Jun 30, 2020 | 10.31M | 1.02M | 11.02% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |